Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
about
Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assemblyApolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteinsHepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthaseHepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expressionSystems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesisHepatitis C virus relies on lipoproteins for its life cycleChaperones in hepatitis C virus infectionHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionModulation of host lipid metabolism by hepatitis C virus: Role of new therapiesChronic hepatitis C virus infection and lipoprotein metabolismHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagyGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationMolecular determinants and dynamics of hepatitis C virus secretionCell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5ALipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesHCV core residues critical for infectivity are also involved in core-NS5A complex formationCoordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5AUltrastructural and biophysical characterization of hepatitis C virus particles produced in cell cultureThe missing pieces of the HCV entry puzzle.Novel permissive cell lines for complete propagation of hepatitis C virus.Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection.Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of FlaviviridaeSelf-assembling peptide nanotubes with antiviral activity against hepatitis C virusThe C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.Specific acquisition of functional CD59 but not CD46 or CD55 by hepatitis C virus.Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particlesProtein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer proteinProduction of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans.Hepatitis C virus life cycle and lipid metabolismDomain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A.GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.Farnesyl-diphosphate farnesyltransferase 1 regulates hepatitis C virus propagation.Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.Last stop before exit - hepatitis C assembly and release as antiviral drug targets.Impact of the autophagy machinery on hepatitis C virus infection.Lipid metabolism and HCV infectionCharacterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
P2860
Q24297412-F2746BEE-D723-408E-95A6-96B58F067643Q24301976-52752F34-EF59-486C-B57B-53BE9A2BF324Q24318935-8E4FD23D-0F3C-4DEC-8FB6-D6F071D54185Q24606745-1E1755BF-4D2B-402F-95DA-6D7664D781E2Q24631218-6D6B6458-EE07-4F30-8798-15CE855C0385Q26766119-2794E7D2-32D6-4499-AF81-CDB43D424316Q26771251-49ECC234-8370-4736-8E25-A50B0D2115EEQ26779128-1A3F3115-6825-49C8-847F-C5581E8CBCD5Q26782009-3C4B3F69-5AA5-4576-AF1F-F9DCB445CDDCQ26784234-7383F4B5-1B68-4B54-BD84-91EDE0627332Q26801207-66BA367A-B8D1-45FF-930E-902BC06FC4D7Q26801759-036FAA54-BEF7-4629-AE0F-01E73B1BF852Q26864485-B5AE00FC-42F3-49AA-BB73-32EAD8E1C557Q27347838-D65F1627-A413-42B0-A65F-FC84218B5AD8Q27469080-5D6BC90A-0C7D-4CC6-A00B-8575EC477C1DQ28081216-5EF1569C-28FD-46B4-B9D6-2A854A2D3B25Q28539751-45C00A4E-23A9-4E04-831A-01F82DCCC1AFQ28551959-07C68DD5-9E73-4572-8095-525BE6EF13D3Q30432551-4E577AE2-6909-496E-A415-5FA148B784BBQ33360674-FC912A76-759C-4FD5-8048-FD4BB60B1063Q33602824-8A5CC1BE-4FDB-454A-8554-78BC9DFBD126Q33853582-ED9EDA16-A525-4CD8-A91F-F11C253F7B27Q33880854-8A216058-3291-4E6A-AF25-AA6F84B0EA36Q34084050-2F83A3F4-CF9D-4459-A83B-A5B92B0DF179Q34190545-728BC427-C6A6-4A7A-A71F-08939D26E3CAQ34295937-843E11D5-C182-4C8B-9B7E-1F75CD335CF2Q34438382-373133E9-35FD-4DA4-957A-B9AF898DE087Q34509568-F2659BD7-E7BD-470E-BAF2-E4231CBEAC71Q34682186-3766CFEF-DA81-47B8-B5E3-47B6B697BFC5Q34719596-1905BB10-C777-44E8-A905-E7F5B11A0F08Q34741763-803BC1D4-8A50-40D4-8B62-513431B93E96Q34792436-DA45691C-E47B-4B07-9077-C1DA8BD53919Q35063336-85E2CFEE-D256-4610-8010-1CCBF2F43F0CQ35114636-62D7F674-4E10-4382-91EC-C07B7981B2A9Q35137045-1A31ABB4-7DC2-42BF-869F-9B1C83E4E443Q35249163-C45EE229-1B79-44A5-8728-96B729B3E98FQ35261158-2B8AD172-D2DA-4187-A517-72E98A4BDB4BQ35261712-AEE042A3-DF98-499C-B6B4-023E90C62128Q35275932-E442F6C8-B520-40E3-8984-C4F7C84E9A6BQ35488198-1D0D40FB-A095-4E16-8EAF-14F618C2AD41
P2860
Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@ast
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@en
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@nl
type
label
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@ast
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@en
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@nl
prefLabel
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@ast
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@en
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@nl
P2860
P3181
P356
P1433
P1476
Apolipoprotein E but Not B Is ...... us Hepatitis C Virus Particles
@en
P2093
Guangxiang Luo
Jieyun Jiang
P2860
P304
P3181
P356
10.1128/JVI.01476-09
P577
2009-12-01T00:00:00Z